PSMA PET-CT in the Diagnosis and Staging of Prostate Cancer

Prostate cancer is the most common cancer and the second leading cause of cancer death in men. The imaging assessment and treatment of prostate cancer has vastly improved over the past decade. The introduction of PSMA PET-CT has improved the detection of loco-regional and metastatic disease. PSMA PE...

Descripción completa

Detalles Bibliográficos
Autores principales: Combes, Alexander D., Palma, Catalina A., Calopedos, Ross, Wen, Lingfeng, Woo, Henry, Fulham, Michael, Leslie, Scott
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9689635/
https://www.ncbi.nlm.nih.gov/pubmed/36359439
http://dx.doi.org/10.3390/diagnostics12112594
Descripción
Sumario:Prostate cancer is the most common cancer and the second leading cause of cancer death in men. The imaging assessment and treatment of prostate cancer has vastly improved over the past decade. The introduction of PSMA PET-CT has improved the detection of loco-regional and metastatic disease. PSMA PET-CT also has a role in the primary diagnosis and staging, in detecting biochemical recurrence after curative treatment and in metastasis-directed therapy. In this paper we review the role of PSMA PET-CT in prostate cancer.

Ejemplares similares